Hester Biosciences consolidated net profit rises 1138.76% in the March 2026 quarter

Sales rise 22.19% to Rs 100.11 crore

Net profit of Hester Biosciences rose 1138.76% to Rs 15.98 crore in the quarter ended March 2026 as against Rs 1.29 crore during the previous quarter ended March 2025. Sales rose 22.19% to Rs 100.11 crore in the quarter ended March 2026 as against Rs 81.93 crore during the previous quarter ended March 2025.

For the full year,net profit rose 102.40% to Rs 55.64 crore in the year ended March 2026 as against Rs 27.49 crore during the previous year ended March 2025. Sales rose 6.91% to Rs 332.60 crore in the year ended March 2026 as against Rs 311.10 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	100.11	81.93	22	332.60	311.10	7
OPM %	34.29	23.41	-	26.06	19.63	-
PBDT	28.06	7.92	254	91.78	56.37	63
PBT	22.15	3.75	491	72.90	39.57	84
NP	15.98	1.29	1139	55.64	27.49	102

Powered by Capital Market - Live News